Progressive supranuclear palsy is a rare condition that affects the brain. The condition is also called Steele-Richardson-Olszewski syndrome. Progressive supranuclear palsy causes the brain cells that ...

Amylyx Pharmaceuticals has discontinued the clinical development program for AMX0035, for the treatment of progressive supranuclear palsy.

Progressive supranuclear palsy (PSP), a mysterious and deadly neurological disorder, usually goes undiagnosed until after a patient dies and an autopsy is performed. But now, UC San Francisco ...

On August 18, GemVax & KAEL announced that it had confirmed statistically significant effects in an interim analysis of its ...

- Topline supports moving to Phase 3 trial and shows potential to develop GV1001 as the world's first PSP treatment PSP is a degenerative disease that, like Parkinson's disease, causes symptoms such ...

A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder ...

Amylyx Pharmaceuticals has discontinued a clinical programme evaluating a neuronal cell death inhibitor as a result of disappointing data when tested as a treatment for a rare brain disorder. Amylyx’s ...

(AVON, Conn.) — Debbie Feldman lived the American dream for most of her adult years — she married her best friend (a prominent attorney), succeeded in her career working as an accountant and raised ...